Rugby Aller-chlor (Chlorpheniramine Maleate Syrup, USP), 2 mg, 4 fl. oz. (120 mL) plastic bottles...

FDA Drug Recall #D-0227-2018 — Class II — August 16, 2017

Recall Summary

Recall Number D-0227-2018
Classification Class II — Moderate risk
Date Initiated August 16, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pharmatech LLC
Location Davie, FL
Product Type Drugs
Quantity Unknown

Product Description

Rugby Aller-chlor (Chlorpheniramine Maleate Syrup, USP), 2 mg, 4 fl. oz. (120 mL) plastic bottles, Distributed by: Rugby Laboratories 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 USA --- NDC: 0536-1025-47, Manufactured by PharmaTech LLC, Davie FL

Reason for Recall

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Distribution Pattern

MI

Lot / Code Information

All lots remaining within expiry.

Other Recalls from Pharmatech LLC

Recall # Classification Product Date
D-0225-2018 Class II Rugby Diocto Syrup, Docusate Sodium 60 mg/15 mL... Aug 16, 2017
D-0224-2018 Class II Rugby Diocto Liquid, Docusate Sodium 50 mg/ 5 m... Aug 16, 2017
D-0226-2018 Class II Rugby Senexon Liquid Natural Vegetable Stimulan... Aug 16, 2017
D-1524-2016 Class II Diocto Syrup (docusate sodium), 60 mg/15 mL, On... Aug 8, 2016
D-1520-2016 Class II Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. ... Aug 8, 2016

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.